Comparison of Breast Cancer Staging Systems After Neoadjuvant Chemotherapy

被引:0
|
作者
Olga Kantor
Alison Laws
Ricardo G. Pastorello
Claire King
Stephanie Wong
Tanujit Dey
Stuart Schnitt
Tari A. King
Elizabeth A. Mittendorf
机构
[1] Brigham and Women’s Hospital,Division of Breast Surgery, Department of Surgery
[2] Dana-Farber/Brigham and Women’s Cancer Center,Breast Oncology Program
[3] McGill University Medical School,Department of Surgery
[4] Brigham and Women’s Hospital,Center for Surgery and Public Health
[5] Brigham and Women’s Hospital,Department of Pathology
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:7347 / 7355
页数:8
相关论文
共 50 条
  • [31] The Prognostic Value of Axillary Staging Following Neoadjuvant Chemotherapy in Inflammatory Breast Cancer
    Monica M. Grova
    Paula D. Strassle
    Emma E. Navajas
    Kristalyn K. Gallagher
    David W. Ollila
    Stephanie M. Downs-Canner
    Philip M. Spanheimer
    Annals of Surgical Oncology, 2021, 28 : 2182 - 2190
  • [32] Validation of a novel staging system for breast cancer patients treated with neoadjuvant chemotherapy
    Mittendorf, E. A.
    Tucker, S. L.
    Jeruss, J. S.
    Gonzalez-Angulo, A. M.
    Buchholz, T. A.
    Sahin, A. A.
    Cormier, J. N.
    Buzdar, A. U.
    Hortobagyi, G. N.
    Hunt, K. K.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [33] Axillary staging prior to neoadjuvant chemotherapy in patients with breast cancer: Predictors of recurrence
    Kilbride, K. E.
    Lee, M. C.
    Nees, A. V.
    Cimmino, A. V.
    Diehl, K. M.
    Sabel, M. S.
    Hayes, D. F.
    Schott, A. F.
    Chang, A. E.
    Newman, L. A.
    ANNALS OF SURGICAL ONCOLOGY, 2008, 15 : 8 - 8
  • [34] The Prognostic Value of Axillary Staging Following Neoadjuvant Chemotherapy in Inflammatory Breast Cancer
    Grova, Monica M.
    Strassle, Paula D.
    Navajas, Emma E.
    Gallagher, Kristalyn K.
    Ollila, David W.
    Downs-Canner, Stephanie M.
    Spanheimer, Philip M.
    ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (04) : 2182 - 2190
  • [35] Bioscore: A novel staging system for breast cancer patients receiving neoadjuvant chemotherapy
    Mittendorf, E. A.
    Vila, J.
    Tucker, S. L.
    Chavez-MacGregor, M.
    Smith, B. D.
    Symmans, W. F.
    Sahin, A. A.
    Hortobagyi, G. N.
    Hunt, K. K.
    CANCER RESEARCH, 2016, 76
  • [36] Reliability on sentinel node biopsy for staging breast cancer treated with neoadjuvant chemotherapy
    Ruano Perez, R.
    Rosero Enriquez, A. S.
    Diaz Gonzalez, L. G.
    Ramos Boyero, M.
    Ramos Grande, T.
    Tamayo, P.
    Garcia-Talavera, J. R.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 : S496 - S496
  • [37] Staging of breast cancer in the neoadjuvant setting
    Jeruss, Jacqueline S.
    Mittendorf, Elizabeth A.
    Tucker, Susan L.
    Gonzalez-Angulo, Ana M.
    Buchholz, Thomas A.
    Sahin, Aysegul A.
    Cormier, Janice N.
    Buzdar, Aman U.
    Hortobagyi, Gabriel N.
    Hunt, Kelly K.
    CANCER RESEARCH, 2008, 68 (16) : 6477 - 6481
  • [38] The timing of breast and axillary surgery after neoadjuvant chemotherapy for breast cancer
    Al-Hilli, Zahraa
    Boughey, Judy C.
    CHINESE CLINICAL ONCOLOGY, 2016, 5 (03)
  • [39] Less invasive axillary staging after neoadjuvant chemotherapy in node-positive breast cancer: A systematic review
    Simons, J.
    Van Nijnatten, T.
    Van der Pol, C.
    Luiten, E.
    Koppert, L.
    Smidt, M.
    EUROPEAN JOURNAL OF CANCER, 2018, 92 : S157 - S157
  • [40] The Neo-Bioscore Update for Staging Breast Cancer Treated With Neoadjuvant Chemotherapy Incorporation of Prognostic Biologic Factors Into Staging After Treatment
    Mittendorf, Elizabeth A.
    Vila, Jose
    Tucker, Susan L.
    Chavez-MacGregor, Mariana
    Smith, Benjamin D.
    Symmans, Fraser
    Sahin, Aysegul A.
    Hortobagyi, Gabriel N.
    Hunt, Kelly K.
    JAMA ONCOLOGY, 2016, 2 (07) : 929 - 936